NCT00349830View on ClinicalTrials.gov

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2032

Study Completion Date

January 31, 2032

Conditions

Carcinomas (Including Squamous Cell and Adenocarcinoma)Neoplasms

Interventions

PROCEDURE

blood draw

Trial Locations (1)

94305

RECRUITING

Stanford University School of Medicine, Stanford

All Listed Sponsors

lead

Stanford University

OTHER